Showing results (61-70 of 524) with videos related to
Sort By:
Pageof 53
Minerva Ginecologica|February 10, 2015
Resveratrol, tryptophanum, glycine and vitamin E: a nutraceutical approach to sleep disturbance and irritability in peri- and post-menopauseF ParazziniHuman Reproduction (Oxford, England)|February 3, 2000
Screening before and during the use of oral contraceptives and hormone replacement therapy. The ESHRE Capri Workshop GroupP G Crosignani, B L RubinHuman Reproduction Update|February 24, 2001
Polycystic ovarian disease: heritability and heterogeneityP G Crosignani, A E NicolosiHuman Reproduction (Oxford, England)|June 1, 1994
Clinical pregnancy and male subfertility; the ESHRE multicentre trial on the treatment of male subfertility. European Society of Human Reproduction and EmbryologyP G Crosignani, D E WaltersHuman Reproduction Update|February 1, 2000
Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogen in women using oral contraception and hormone replacement therapy. ESHRE Capri Workshop GroupP G Crosignani, C La VecchiaHuman Reproduction (Oxford, England)|February 25, 2000
Optimal use of infertility diagnostic tests and treatments. The ESHRE Capri Workshop GroupP G Crosignani, B L RubinInternational Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 1, 1992
Unexplained infertility: a review of diagnosis, prognosis, treatment efficacy and managementJ A Collins, P G CrosignaniHuman Reproduction (Oxford, England)|July 1, 1995
Cabergoline: a new drug for the treatment of hyperprolactinaemiaC Ferrari, G Piscitelli, P G CrosignaniThe European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|July 25, 1998
Hormonal contraception and ovarian pathologyP G Crosignani, W Vegetti, D BianchediHuman Reproduction (Oxford, England)|May 1, 1992
Is mild endometriosis always a disease?P Vercellini, L Bocciolone, P G CrosignaniPageof 53